Kaitlyn Sturmer, PA
Physician Assistant · Saint Louis, MONPI 1003445404
Payments from drug & device makers
Across 98 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$376
- Novo Nordisk$274
- AbbVie$213
- GSK$97
- Valinor Pharma, LLC$77
- Exact Sciences$65
- plus $660 from 24 others
What the payments were for
- Food & beverage$1,762100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 17 | $376 |
| Novo Nordisk | 18 | $274 |
| AbbVie | 11 | $213 |
| GSK | 6 | $97 |
| Valinor Pharma, LLC | 5 | $77 |
| Exact Sciences | 3 | $65 |
| Novartis | 4 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $56 |
| Pfizer | 3 | $43 |
| Amgen | 2 | $36 |
| Boehringer Ingelheim | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Lundbeck LLC | 2 | $32 |
| Seagen Inc. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| AstraZeneca | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Bayer | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Medtronic | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Viatris Specialty LLC | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Merck | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $14 |
How this compares
$1,762 in reported general payments places this provider in the 80th percentile of 1,380 physician assistant providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 22 | $29,007 |
| MounjaroTirzepatide | 12 | $12,928 |
| EliquisApixaban | 12 | $12,580 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $8,293 |
| XareltoRivaroxaban | 13 | $7,308 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 89 | $1,641 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 17 | $1,463 |
| Atorvastatin Calcium | 88 | $842 |
| Diclofenac Sodium | 68 | $744 |
| Ropinirole Hcl | 27 | $594 |
| Buspirone Hcl | 42 | $567 |
| Omeprazole | 46 | $561 |
| Bupropion XlBupropion Hcl | 20 | $501 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $477 |
| Bisoprolol-HydrochlorothiazideBisoprolol/Hydrochlorothiazide | 26 | $474 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $274 | $29,00722 claims |
| Lilly USA, LLCMounjaro | $376 | $12,92812 claims |
| PfizerEliquis | $43 | $12,58012 claims |
| GSKTrelegy Ellipta | $97 | $8,29311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,380 physician assistant providers in Missouri.
Other physician assistant in Saint Louis
- Kimberly BrownSaint Louis$28K
- Michael HesselSaint Louis$19K
- Erica WestbrooksSaint Louis$19K
- Christine EdwardsSaint Louis$18K
- Andrea MartinSaint Louis$17K
- Rachael HartkeSaint Louis$16K
- Kristen SchreiberSaint Louis$14K
- Jonathan PriceSaint Louis$10K
- Yongzhong WeiSaint Louis$9K
- Lisa RoelleSaint Louis$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.